Transmission and epidemiology of zoonotic protozoal diseases of companion animals

Clinical Microbiology Reviews

Volumn 26, Issue 1, 2013, Pages 58-85

  Esch, Kevin J ^a   Petersen, Christine A ^a  

^a IOWA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DELTAMETHRIN; DIETHYLTOLUAMIDE; INSECTICIDE; PERMETHRIN;

ARTICLE; CHAGAS DISEASE; COMORBIDITY; DISEASE TRANSMISSION; GIARDIASIS; HUMAN; IMMUNITY; INSECT BITE; LEISHMANIASIS; MICROBIAL GROWTH; NONHUMAN; PARASITE VIRULENCE; PATHOGENESIS; PET ANIMAL; PIROPLASMOSIS; PROTIST LIFE CYCLE STAGE; PROTOZOAL INFECTION; RISK FACTOR; SANITATION; SEROPREVALENCE; TOXOPLASMOSIS; ZOONOSIS;

ANIMALS; CAT DISEASES; CATS; DOG DISEASES; DOGS; HUMANS; INCIDENCE; PARASITIC DISEASES; PARASITIC DISEASES, ANIMAL; PETS; UNITED STATES; ZOONOSES;

ANIMALIA; CANIS FAMILIARIS; GIARDIA; TOXOPLASMA GONDII; TRYPANOSOMA CRUZI;

EID: 84872190213     PISSN: 08938512     EISSN: 10986618     Source Type: Journal    
DOI: 10.1128/CMR.00067-12     Document Type: Article

References (350)

1. APPA. 2012. APPA national pet owners survey 2011-2012. APPA, Washington, DC. http://www.americanpetproducts.org/press_industrytrends.asp.
2. Krause-Parello CA. 2012. Pet ownership and older women: the relationships among loneliness, pet attachment support, human social support, and depressed mood. Geriatr. Nurs. 33:194-203.
3. McConnell AR, Brown CM, Shoda TM, Stayton LE, Martin CE. 2011. Friends with benefits: on the positive consequences of pet ownership. J. Pers. Soc. Psychol. 101:1239-1252.
4. Larsen BA, Lingaas F. 1997. Dogs and health. A review of documented connections. Tidsskr. Nor. Laegeforen. 117:4375-4379. (In Norwegian.)
5. Raina P, Waltner-Toews D, Bonnett B, Woodward C, Abernathy T. 1999. Influence of companion animals on the physical and psychological health of older people: an analysis of a one-year longitudinal study. J. Am. Geriatr. Soc. 47:323-329.
6. Ballweber LR, Xiao L, Bowman DD, Kahn G, Cama VA. 2010. Giardiasis in dogs and cats: update on epidemiology and public health significance. Trends Parasitol. 26:180-189.
7. Jones JL, Dargelas V, Roberts J, Press C, Remington JS, Montoya JG. 2009. Risk factors for Toxoplasma gondii infection in the United States. Clin. Infect. Dis. 49:878-884.
8. Barr SC. 2009. Canine Chagas' disease (American trypanosomiasis) in North America. Vet. Clin. North Am. Small Anim. Pract. 39:1055-1064.
9. Petersen CA. 2009. Leishmaniasis, an emerging disease found in companion animals in the United States. Top. Companion Anim. Med. 24: 182-188.
10. Chuang YM, Ho YC, Chang HT, Yu CJ, Yang PC, Hsueh PR. 2008. Disseminated cryptococcosis in HIV-uninfected patients. Eur. J. Clin. Microbiol. 27:307-310.
11. Cribier BJ, Bakshi R. 2004. Terbinafine in the treatment of onychomycosis: a review of its efficacy in high-risk populations and in patients with nondermatophyte infections. Br. J. Dermatol. 150:414-420.
12. Dubey JP, Lindsay DS, Lappin MR. 2009. Toxoplasmosis and other intestinal coccidial infections in cats and dogs. Vet. Clin. North Am. Small Anim. Pract 39:1009-1034.
13. Dubey JP. 2009. History of the discovery of the life cycle of Toxoplasma gondii. Int. J. Parasitol. 39:877-882.
14. Elmore SA, Jones JL, Conrad PA, Patton S, Lindsay DS, Dubey JP. 2010. Toxoplasma gondii: epidemiology, feline clinical aspects, and prevention. Trends Parasitol. 26:190-196.
15. Malmasi A, Mosallanejad B, Mohebali M, Sharifian Fard M, Taheri M. 2009. Prevention of shedding and re-shedding of Toxoplasma gondii oocysts in experimentally infected cats treated with oral clindamycin: a preliminary study. Zoonoses Public Health 56:102-104.
16. Dubey JP, Frenkel JK. 1976. Feline toxoplasmosis from acutely infected mice and the development of Toxoplasma cysts. J. Protozool. 23:537-546.
17. Yoshida N, Tyler KM, Llewellyn MS. 2011. Invasion mechanisms among emerging food-borne protozoan parasites. Trends Parasitol. 27: 459-466.
18. Carruthers V, Boothroyd JC. 2007. Pulling together: an integrated model of Toxoplasma cell invasion. Curr. Opin. Microbiol. 10:83-89.
19. Dubey JP. 2006. Comparative infectivity of oocysts and bradyzoites of Toxoplasma gondii for intermediate (mice) and definitive (cats) hosts. Vet. Parasitol. 140:69-75.
20. Jones JL, Kruszon-Moran D, Wilson M, McQuillan G, Navin T, McAuley JB. 2001. Toxoplasma gondii infection in the United States: seroprevalence and risk factors. Am. J. Epidemiol. 154:357-365.
21. Weiss LM, Dubey JP. 2009. Toxoplasmosis: a history of clinical observations. Int. J. Parasitol. 39:895-901.
22. Lang C, Gross U, Luder CG. 2007. Subversion of innate and adaptive immune responses by Toxoplasma gondii. Parasitol. Res. 100:191-203.
23. Munoz M, Liesenfeld O, Heimesaat MM. 2011. Immunology of Toxoplasma gondii. Immunol. Rev. 240:269-285.
24. Saeij JP, Boyle JP, Coller S, Taylor S, Sibley LD, Brooke-Powell ET, Ajioka JW, Boothroyd JC. 2006. Polymorphic secreted kinases are key virulence factors in toxoplasmosis. Science 314:1780-1783.
25. Saeij JP, Coller S, Boyle JP, Jerome ME, White MW, Boothroyd JC. 2007. Toxoplasma co-opts host gene expression by injection of a polymorphic kinase homologue. Nature 445:324-327.
26. Butcher BA, Kim L, Panopoulos AD, Watowich SS, Murray PJ, Denkers EY. 2005. IL-10-independent STAT3 activation by Toxoplasma gondii mediates suppression of IL-12 and TNF-alpha in host macrophages. J. Immunol. 174:3148-3152.
27. Lang C, Algner M, Beinert N, Gross U, Luder CG. 2006. Diverse mechanisms employed by Toxoplasma gondii to inhibit IFN-gammainduced major histocompatibility complex class II gene expression. Microbes Infect. 8:1994-2005.
28. Khan IA, Matsuura T, Kasper LH. 1995. IL-10 mediates immunosuppression following primary infection with Toxoplasma gondii in mice. Parasite Immunol. 17:185-195.
29. Santos TA, Portes JA, Damasceno-Sa JC, Caldas LA, Souza W, Damatta RA, Seabra SH. 2011. Phosphatidylserine exposure by Toxoplasma gondii is fundamental to balance the immune response granting survival of the parasite and of the host. PLoS One 6:e27867. doi:10.1371 /journal.pone.0027867.
30. Vutova P, Wirth M, Hippe D, Gross U, Schulze-Osthoff K, Schmitz I, Luder CG. 2007. Toxoplasma gondii inhibits Fas/CD95-triggered cell death by inducing aberrant processing and degradation of caspase 8. Cell. Microbiol. 9:1556-1570.
31. Khan IA, Matsuura T, Kasper LH. 1996. Activation-mediated CD4+ T cell unresponsiveness during acute Toxoplasma gondii infection in mice. Int. Immunol. 8:887-896.
32. Nash PB, Purner MB, Leon RP, Clarke P, Duke RC, Curiel TJ. 1998. Toxoplasma gondii-infected cells are resistant to multiple inducers of apoptosis. J. Immunol. 160:1824-1830.
33. House PK, Vyas A, Sapolsky R. 2011. Predator cat odors activate sexual arousal pathways in brains of Toxoplasma gondii infected rats. PLoS One 6:e23277. doi:10.1371/journal.pone.0023277.
34. Lindsay DS, Dubey JP, Butler JM, Blagburn BL. 1997. Mechanical transmission of Toxoplasma gondii oocysts by dogs. Vet. Parasitol. 73: 27-33.
35. Vollaire MR, Radecki SV, Lappin MR. 2005. Seroprevalence of Toxoplasma gondii antibodies in clinically ill cats in the United States. Am. J. Vet. Res. 66:874-877.
36. Jones JL, Kruszon-Moran D, Sanders-Lewis K, Wilson M. 2007. Toxoplasma gondii infection in the United States, 1999-2004, decline from the prior decade. Am. J. Trop. Med. Hyg. 77:405-410.
37. Robert-Gangneux F, Darde ML. 2012. Epidemiology of and diagnostic strategies for toxoplasmosis. Clin. Microbiol. Rev. 25:264-296.
38. Pappas G, Roussos N, Falagas ME. 2009. Toxoplasmosis snapshots: global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis. Int. J. Parasitol. 39:1385-1394.
39. Conrad PA, Miller MA, Kreuder C, James ER, Mazet J, Dabritz H, Jessup DA, Gulland F, Grigg ME. 2005. Transmission of Toxoplasma: clues from the study of sea otters as sentinels of Toxoplasma gondii flow into the marine environment. Int. J. Parasitol. 35:1155-1168.
40. Shapiro K, Conrad PA, Mazet JA, Wallender WW, Miller WA, Largier JL. 2010. Effect of estuarine wetland degradation on transport of Toxoplasma gondii surrogates from land to sea. Appl. Environ. Microbiol. 76:6821-6828.
41. Dubey JP, Hill DE, Jones JL, Hightower AW, Kirkland E, Roberts JM, Marcet PL, Lehmann T, Vianna MC, Miska K, Sreekumar C, Kwok OC, Shen SK, Gamble HR. 2005. Prevalence of viable Toxoplasma gondii in beef, chicken, and pork from retail meat stores in the United States: risk assessment to consumers. J. Parasitol. 91:1082-1093.
42. Boyer K, Hill D, Mui E, Wroblewski K, Karrison T, Dubey JP, Sautter M, Noble AG, Withers S, Swisher C, Heydemann P, Hosten T, Babiarz J, Lee D, Meier P, McLeod R. 2011. Unrecognized ingestion of Toxoplasma gondii oocysts leads to congenital toxoplasmosis and causes epidemics in North America. Clin. Infect. Dis. 53:1081-1089.
43. Holland GN. 2003. Ocular toxoplasmosis: a global reassessment. Part I: epidemiology and course of disease. Am. J. Ophthalmol. 136:973-988.
44. Villena I, Ancelle T, Delmas C, Garcia P, Brezin AP, Thulliez P, Wallon M, King L, Goulet V. 2010. Congenital toxoplasmosis in France in 2007: first results from a national surveillance system. Euro Surveill. 15(25):pii=19600.http://www.eurosurveillance.org/View Article.aspx-?ArticleId=19600.
45. Jones JL, Roberts JM. 2012. Toxoplasmosis hospitalizations in the United States, 2008, and trends, 1993-2008. Clin. Infect. Dis. 54:e58-61.
46. Yoder JS, Harral C, Beach MJ. 2010. Giardiasis surveillance-United States, 2006-2008. MMWR Surveill. Summ. 59:15-25.
47. Yoder JS, Beach MJ. 2007. Giardiasis surveillance-United States, 2003- 2005. MMWR Surveill. Summ. 56:11-18.
48. Feng Y, Xiao L. 2011. Zoonotic potential and molecular epidemiology of Giardia species and giardiasis. Clin. Microbiol. Rev. 24:110-140.
49. Covacin C, Aucoin DP, Elliot A, Thompson RC. 2011. Genotypic characterisation of Giardia from domestic dogs in the USA. Vet. Parasitol. 177:28-32.
50. Ankarklev J, Jerlstrom-Hultqvist J, Ringqvist E, Troell K, Svard SG. 2010. Behind the smile: cell biology and disease mechanisms of Giardia species. Nat. Rev. Microbiol. 8:413-422.
51. Rendtorff RC. 1954. The experimental transmission of human intestinal protozoan parasites. II. Giardia lamblia cysts given in capsules. Am. J. Hyg. (Lond.) 59:209-220.
52. Hetsko ML, McCaffery JM, Svard SG, Meng TC, Que X, Gillin FD. 1998. Cellular and transcriptional changes during excystation of Giardia lamblia in vitro. Exp. Parasitol. 88:172-183.
53. Reiner DS, Hetsko ML, Meszaros JG, Sun CH, Morrison HG, Brunton LL, Gillin FD. 2003. Calcium signaling in excystation of the early diverging eukaryote, Giardia lamblia. J. Biol. Chem. 278:2533-2540.
54. Ward W, Alvarado L, Rawlings ND, Engel JC, Franklin C, McKerrow JH. 1997. A primitive enzyme for a primitive cell: the protease required for excystation of Giardia. Cell 89:437-444.
55. Slavin I, Saura A, Carranza PG, Touz MC, Nores MJ, Lujan HD. 2002. Dephosphorylation of cyst wall proteins by a secreted lysosomal acid phosphatase is essential for excystation of Giardia lamblia. Mol. Biochem. Parasitol. 122:95-98.
56. Bernander R, Palm JE, Svard SG. 2001. Genome ploidy in different stages of the Giardia lamblia life cycle. Cell. Microbiol. 3:55-62.
57. Hagen KD, Hirakawa MP, House SA, Schwartz CL, Pham JK, Cipriano MJ, De La Torre MJ, Sek AC, Du G, Forsythe BM, Dawson SC. 2011. Novel structural components of the ventral disc and lateral crest in Giardia intestinalis. PLoS Negl. Trop. Dis. 5:e1442. doi:10.1371/journal.pntd.0001442.
58. Jenkins MC, O'Brien CN, Murphy C, Schwarz R, Miska K, Rosenthal B, Trout JM. 2009. Antibodies to the ventral disc protein delta-giardin prevent in vitro binding of Giardia lamblia trophozoites. J. Parasitol. 95:895-899.
59. Chin AC, Teoh DA, Scott KG, Meddings JB, Macnaughton WK, Buret AG. 2002. Strain-dependent induction of enterocyte apoptosis by Giardia lamblia disrupts epithelial barrier function in a caspase-3-dependent manner. Infect. Immun. 70:3673-3680.
60. Panaro MA, Cianciulli A, Mitolo V, Mitolo CI, Acquafredda A, Brandonisio O, Cavallo P. 2007. Caspase-dependent apoptosis of the HCT-8 epithelial cell line induced by the parasite Giardia intestinalis. FEMS Immunol. Med. Microbiol. 51:302-309.
61. Scott KG, Meddings JB, Kirk DR, Lees-Miller SP, Buret AG. 2002. Intestinal infection with Giardia spp. reduces epithelial barrier function in a myosin light chain kinase-dependent fashion. Gastroenterology 123: 1179-1190.
62. Buret AG, Mitchell K, Muench DG, Scott KG. 2002. Giardia lamblia disrupts tight junctional ZO-1 and increases permeability in nontransformed human small intestinal epithelial monolayers: effects of epidermal growth factor. Parasitology 125:11-19.
63. Troeger H, Epple HJ, Schneider T, Wahnschaffe U, Ullrich R, Burchard GD, Jelinek T, Zeitz M, Fromm M, Schulzke JD. 2007. Effect of chronic Giardia lamblia infection on epithelial transport and barrier function in human duodenum. Gut 56:328-335.
64. Prucca CG, Rivero FD, Lujan HD. 2011. Regulation of antigenic variation in Giardia lamblia. Annu. Rev. Microbiol. 65:611-630.
65. Cotton JA, Beatty JK, Buret AG. 2011. Host parasite interactions and pathophysiology in Giardia infections. Int. J. Parasitol. 41:925-933.
66. Roxstrom-Lindquist K, Palm D, Reiner D, Ringqvist E, Svard SG. 2006. Giardia immunity-an update. Trends Parasitol. 22:26-31.
67. Solaymani-Mohammadi S, Singer SM. 2010. Giardia duodenalis: the double-edged sword of immune responses in giardiasis. Exp. Parasitol. 126:292-297.
68. Yoder JS, Hlavsa MC, Craun GF, Hill V, Roberts V, Yu PA, Hicks LA, Alexander NT, Calderon RL, Roy SL, Beach MJ. 2008. Surveillance for waterborne disease and outbreaks associated with recreational water use and other aquatic facility-associated health events-United States, 2005-2006. MMWR Surveill. Summ. 57:1-29.
69. Daly ER, Roy SJ, Blaney DD, Manning JS, Hill VR, Xiao L, Stull JW. 2010. Outbreak of giardiasis associated with a community drinkingwater source. Epidemiol. Infect. 138:491-500.
70. Yoder J, Roberts V, Craun GF, Hill V, Hicks LA, Alexander NT, Radke V, Calderon RL, Hlavsa MC, Beach MJ, Roy SL. 2008. Surveillance for waterborne disease and outbreaks associated with drinking water and water not intended for drinking-United States, 2005-2006. MMWR Surveill. Summ. 57:39-62.
71. Brunkard JM, Ailes E, Roberts VA, Hill V, Hilborn ED, Craun GF, Rajasingham A, Kahler A, Garrison L, Hicks L, Carpenter J, Wade TJ, Beach MJ, Yoder JS. 2011. Surveillance for waterborne disease outbreaks associated with drinking water-United States, 2007-2008. MMWR Surveill. Summ. 60:38-68.
72. Craun GF, Brunkard JM, Yoder JS, Roberts VA, Carpenter J, Wade T, Calderon RL, Roberts JM, Beach MJ, Roy SL. 2010. Causes of outbreaks associated with drinking water in the United States from 1971 to 2006. Clin. Microbiol. Rev. 23:507-528.
73. Goncalves AL, Belizario TL, Pimentel JB, Penatti MP, Pedroso RS. 2011. Prevalence of intestinal parasites in preschool children in the region of Uberlandia, State of Minas Gerais, Brazil. Rev. Soc. Bras. Med. Trop. 44:191-193.
74. Matos SM, Assis AM, Prado MS, Strina A, Santos LA, Jesus SR, Barreto ML. 2008. Giardia duodenalis infection and anthropometric status in preschoolers in Salvador, Bahia State, Brazil. Cad. Saude Publica 24:1527-1535.
75. de Souza EA, da Silva-Nunes M, Malafronte RS, Muniz PT, Cardoso MA, Ferreira MU. 2007. Prevalence and spatial distribution of intestinal parasitic infections in a rural Amazonian settlement, Acre State, Brazil. Cad. Saude Publica 23:427-434.
76. Molina N, Minvielle M, Grenovero S, Salomon C, Basualdo J. 2011. High prevalences of infection with Giardia intestinalis genotype B among children in urban and rural areas of Argentina. Ann. Trop. Med. Parasitol. 105:299-309.
77. Laishram S, Kang G, Ajjampur SS. 2012. Giardiasis: a review on assemblage distribution and epidemiology in India. Indian J. Gastroenterol. 31:3-12.
78. Dib HH, Lu SQ, Wen SF. 2008. Prevalence of Giardia lamblia with or without diarrhea in South East, South East Asia and the Far East. Parasitol. Res. 103:239-251.
79. Tangtrongsup S, Scorza V. 2010. Update on the diagnosis and management of Giardia spp infections in dogs and cats. Top. Companion Anim. Med. 25:155-162.
80. Mark-Carew MP, Wade SE, Chang YF, Schaaf S, Mohammed HO. 2012. Prevalence of Giardia duodenalis assemblages among dairy herds in the New York City watershed. Vet. Parasitol. 185:151-157.
81. Feng Y, Ortega Y, Cama V, Terrel J, Xiao L. 2008. High intragenotypic diversity of Giardia duodenalis in dairy cattle on three farms. Parasitol. Res. 103:87-92.
82. Geurden T, Thomas P, Casaert S, Vercruysse J, Claerebout E. 2008. Prevalence and molecular characterisation of Cryptosporidium and Giardia in lambs and goat kids in Belgium. Vet. Parasitol. 155:142-145.
83. Santin M, Dargatz D, Fayer R. 2012. Prevalence of Giardia duodenalis assemblages in weaned cattle on cow-calf operations in the United States. Vet. Parasitol. 183:231-236.
84. Stuart JM, Orr HJ, Warburton FG, Jeyakanth S, Pugh C, Morris I, Sarangi J, Nichols G. 2003. Risk factors for sporadic giardiasis: a casecontrol study in southwestern England. Emerg. Infect. Dis. 9:229-233.
85. Welch TP. 2000. Risk of giardiasis from consumption of wilderness water in North America: a systematic review of epidemiologic data. Int. J. Infect. Dis. 4:100-103.
86. Hoque ME, Hope VT, Kjellstrom T, Scragg R, Lay-Yee R. 2002. Risk of giardiasis in Aucklanders: a case-control study. Int. J. Infect. Dis. 6:191-197.
87. Coles CL, Levy A, Dagan R, Deckelbaum RJ, Fraser D. 2009. Risk factors for the initial symptomatic Giardia infection in a cohort of young Arab-Bedouin children. Ann. Trop. Paediatr. 29:291-300.
88. Novotny TE, Hopkins RS, Shillam P, Janoff EN. 1990. Prevalence of Giardia lamblia and risk factors for infection among children attending day-care facilities in Denver. Public Health Rep. 105:72-75.
89. Hlavsa MC, Roberts VA, Anderson AR, Hill VR, Kahler AM, Orr M, Garrison LE, Hicks LA, Newton A, Hilborn ED, Wade TJ, Beach MJ, Yoder JS. 2011. Surveillance for waterborne disease outbreaks and other health events associated with recreational water-United States, 2007- 2008. MMWR Surveill. Summ. 60:1-32.
90. Julio C, Vilares A, Oleastro M, Ferreira I, Gomes S, Monteiro L, Nunes B, Tenreiro R, Angelo H. 2012. Prevalence and risk factors for Giardia duodenalis infection among children: a case study in Portugal. Parasit. Vectors 5:22. doi:10.1186/1756-3305-5-22.
91. Moreira ED, Jr, Nassri VB, Santos RS, Matos JF, de Carvalho WA, Silvani CS, Santana e Sant'ana C. 2005. Association of Helicobacter pylori infection and giardiasis: results from a study of surrogate markers for fecal exposure among children. World J. Gastroenterol. 11:2759-2763.
92. Center for Food Safety and Public Health. 1 May 2005, posting date. Giardiasis technical fact sheet. Iowa State University, Ames, IA. http://www.cfsph.iastate.edu/Factsheets/pdfs/giardiasis.pdf.
93. Babes V. 1888. Sur l'hémoglobinurie bactérienne duboeuf. C. R. Hebd. Seances Acad. Sci. 107:692-694.
94. Uilenberg G. 2006. Babesia-a historical overview. Vet. Parasitol. 138: 3-10.
95. Gohil S, Kats LM, Sturm A, Cooke BM. 2010. Recent insights into alteration of red blood cells by Babesia bovis: moovin' forward. Trends Parasitol. 26:591-599.
96. Gray J, Zintl A, Hildebrandt A, Hunfeld KP, Weiss L. 2010. Zoonotic babesiosis: overview of the disease and novel aspects of pathogen identity. Ticks Tick Borne Dis. 1:3-10.
97. Johnson ST, Cable RG, Tonnetti L, Spencer B, Rios J, Leiby DA. 2009. Seroprevalence of Babesia microti in blood donors from Babesiaendemic areas of the northeastern United States: 2000 through 2007. Transfusion 49:2574-2582.
98. Magnarelli LA, Stafford KC, III, Ijdo JW, Fikrig E. 2006. Antibodies to whole-cell or recombinant antigens of Borrelia burgdorferi, Anaplasma phagocytophilum, and Babesia microti in white-footed mice. J. Wildl. Dis. 42:732-738.
99. Leiby DA, Chung AP, Gill JE, Houghton RL, Persing DH, Badon S, Cable RG. 2005. Demonstrable parasitemia among Connecticut blood donors with antibodies to Babesia microti. Transfusion 45:1804-1810.
100. Centers for Disease Control and Prevention. 2012. Babesiosis surveillance- 18 states, 2011. MMWR Morb. Mortal. Wkly. Rep. 61:505-509.
101. Quick RE, Herwaldt BL, Thomford JW, Garnett ME, Eberhard ML, Wilson M, Spach DH, Dickerson JW, Telford SR, III, Steingart KR, Pollock R, Persing DH, Kobayashi JM, Juranek DD, Conrad PA. 1993. Babesiosis in Washington State: a new species of Babesia? Ann. Intern. Med. 119:284-290.
102. Kjemtrup AM, Lee B, Fritz CL, Evans C, Chervenak M, Conrad PA. 2002. Investigation of transfusion transmission of a WA1-type babesial parasite to a premature infant in California. Transfusion 42:1482-1487.
103. Herwaldt BL, Kjemtrup AM, Conrad PA, Barnes RC, Wilson M, McCarthy MG, Sayers MH, Eberhard ML. 1997. Transfusiontransmitted babesiosis in Washington State: first reported case caused by a WA1-type parasite. J. Infect. Dis. 175:1259-1262.
104. Prince HE, Lape-Nixon M, Patel H, Yeh C. 2010. Comparison of the Babesia duncani (WA1) IgG detection rates among clinical sera submitted to a reference laboratory for WA1 IgG testing and blood donor specimens from diverse geographic areas of the United States. Clin. Vaccine Immunol. 17:1729-1733.
105. Bloch EM, Herwaldt BL, Leiby DA, Shaieb A, Herron RM, Chervenak M, Reed W, Hunter R, Ryals R, Hagar W, Xayavong MV, Slemenda SB, Pieniazek NJ, Wilkins PP, Kjemtrup AM. 2012. The third described case of transfusion-transmitted Babesia duncani. Transfusion 52:1517-1522.
106. Persing DH, Herwaldt BL, Glaser C, Lane RS, Thomford JW, Mathiesen D, Krause PJ, Phillip DF, Conrad PA. 1995. Infection with a Babesia-like organism in northern California. N. Engl. J. Med. 332:298-303.
107. Herwaldt B, Persing DH, Precigout EA, Goff WL, Mathiesen DA, Taylor PW, Eberhard ML, Gorenflot AF. 1996. A fatal case of babesiosis in Missouri: identification of another piroplasm that infects humans. Ann. Intern. Med. 124:643-650.
108. Herwaldt BL, de Bruyn G, Pieniazek NJ, Homer M, Lofy KH, Slemenda SB, Fritsche TR, Persing DH, Limaye AP. 2004. Babesia divergens- like infection, Washington State. Emerg. Infect. Dis. 10:622-629.
109. Beattie JF, Michelson ML, Holman PJ. 2002. Acute babesiosis caused by Babesia divergens in a resident of Kentucky. N. Engl. J. Med. 347:697-698.
110. Yabsley MJ, Romines J, Nettles VF. 2006. Detection of Babesia and Anaplasma species in rabbits from Texas and Georgia, USA. Vector Borne Zoonotic Dis. 6:7-13.
111. Yamane I, Gardner IA, Ryan CP, Levy M, Urrico J, Conrad PA. 1994. Serosurvey of Babesia canis, Babesia gibsoni, and Erlichia canis in pound dogs in California, USA. Prev. Vet. Med. 18:293-304.
112. Hasle G, Bjune GA, Christensson D, Roed KH, Whist AC, Leinaas HP. 2010. Detection of Babesia divergens in southern Norway by using an immunofluorescence antibody test in cow sera. Acta Vet. Scand. 52:55. doi:10.1186/1751-0147-52-55.
113. Lempereur L, Lebrun M, Cuvelier P, Sepult G, Caron Y, Saegerman C, Shiels B, Losson B. 2012. Longitudinal field study on bovine Babesia spp. and Anaplasma phagocytophilum infections during a grazing season in Belgium. Parasitol. Res. 110:1525-1530.
114. Devos J, Geysen D. 2004. Epidemiological study of the prevalence of Babesia divergens in a veterinary practice in the mid-east of France. Vet. Parasitol. 125:237-249.
115. Tampieri MP, Galuppi R, Bonoli C, Cancrini G, Moretti A, Pietrobelli M. 2008. Wild ungulates as Babesia hosts in northern and central Italy. Vector Borne Zoonotic Dis. 8:667-674.
116. Cassini R, Marcer F, di Regalbono AF, Cancrini G, Gabrielli S, Moretti A, Galuppi R, Tampieri MP, Pietrobelli M. 2012. New insights into the epidemiology of bovine piroplasmoses in Italy. Vet. Parasitol. 184: 77-82.
117. Hunfeld KP, Lambert A, Kampen H, Albert S, Epe C, Brade V, Tenter AM. 2002. Seroprevalence of Babesia infections in humans exposed to ticks in midwestern Germany. J. Clin. Microbiol. 40:2431-2436.
118. Maamun JM, Suleman MA, Akinyi M, Ozwara H, Kariuki T, Carlsson HE. 2011. Prevalence of Babesia microti in free-ranging baboons and African green monkeys. J. Parasitol. 97:63-67.
119. Bonnet S, Jouglin M, L'Hostis M, Chauvin A. 2007. Babesia sp. EU1 from roe deer and transmission within Ixodes ricinus. Emerg. Infect. Dis. 13:1208-1210.
120. Duh D, Petrovec M, Avsic-Zupanc T. 2005. Molecular characterization of human pathogen Babesia EU1 in Ixodes ricinus ticks from Slovenia. J. Parasitol. 91:463-465.
121. Herwaldt BL, Caccio S, Gherlinzoni F, Aspock H, Slemenda SB, Piccaluga P, Martinelli G, Edelhofer R, Hollenstein U, Poletti G, Pampiglione S, Loschenberger K, Tura S, Pieniazek NJ. 2003. Molecular characterization of a non-Babesia divergens organism causing zoonotic babesiosis in Europe. Emerg. Infect. Dis. 9:942-948.
122. Haselbarth K, Tenter AM, Brade V, Krieger G, Hunfeld KP. 2007. First case of human babesiosis in Germany-clinical presentation and molecular characterisation of the pathogen. Int. J. Med. Microbiol. 297:197-204.
123. Centeno-Lima S, do Rosario V, Parreira R, Maia AJ, Freudenthal AM, Nijhof AM, Jongejan F. 2003. A fatal case of human babesiosis in Portugal: molecular and phylogenetic analysis. Trop. Med. Int. Health 8:760-764.
124. Calvo de Mora A, Garcia Castellano JM, Herrera C, Jimenez-Alonso J. 1985. Human babesiosis: report of a case with fatal outcome. Med. Clin. (Barc.) 85:515-516. (In Spanish.)
125. Gorenflot A, Moubri K, Precigout E, Carcy B, Schetters TP. 1998. Human babesiosis. Ann. Trop. Med. Parasitol. 92:489-501.
126. Terkawi MA, Thekisoe OM, Katsande C, Latif AA, Mans BJ, Matthee O, Mkize N, Mabogoane N, Marais F, Yokoyama N, Xuan X, Igarashi I. 2011. Serological survey of Babesia bovis and Babesia bigemina in cattle in South Africa. Vet. Parasitol. 182:337-342.
127. Iseki H, Zhou L, Kim C, Inpankaew T, Sununta C, Yokoyama N, Xuan X, Jittapalapong S, Igarashi I. 2010. Seroprevalence of Babesia infections of dairy cows in northern Thailand. Vet. Parasitol. 170:193-196.
128. Silva MG, Henriques G, Sanchez C, Marques PX, Suarez CE, Oliva A. 2009. First survey for Babesia bovis and Babesia bigemina infection in cattle from Central and Southern regions of Portugal using serological and DNA detection methods. Vet. Parasitol. 166:66-72.
129. Urdaz-Rodriguez JH, Fosgate GT, Waghela SD, Alleman AR, Rae DO, Donovan GA, Melendez P. 2009. Seroprevalence estimation and management factors associated with high herd seropositivity for Babesia bovis in commercial dairy farms of Puerto Rico. Trop. Anim. Health Prod. 41:1465-1473.
130. Barros SL, Madruga CR, Araujo FR, Menk CF, de Almeida MA, Melo EP, Kessler RH. 2005. Serological survey of Babesia bovis, Babesia bigemina, and Anaplasma marginale antibodies in cattle from the semiarid region of the state of Bahia, Brazil, by enzyme-linked immunosorbent assays. Mem. Inst. Oswaldo Cruz 100:513-517.
131. Cassini R, Zanutto S, Frangipane di Regalbono A, Gabrielli S, Calderini P, Moretti A, Tampieri MP, Pietrobelli M. 2009. Canine piroplasmosis in Italy: epidemiological aspects in vertebrate and invertebrate hosts. Vet. Parasitol. 165:30-35.
132. Beck R, Vojta L, Mrljak V, Marinculic A, Beck A, Zivicnjak T, Caccio SM. 2009. Diversity of Babesia and Theileria species in symptomatic and asymptomatic dogs in Croatia. Int. J. Parasitol. 39:843-848.
133. Bourdoiseau G. 2006. Canine babesiosis in France. Vet. Parasitol. 138: 118-125.
134. Wudhikarn K, Perry EH, Kemperman M, Jensen KA, Kline SE. 2011. Transfusion-transmitted babesiosis in an immunocompromised patient: a case report and review. Am. J. Med. 124:800-805.
135. Jasmer DP, Reduker DW, Hines SA, Perryman LE, McGuire TC. 1992. Surface epitope localization and gene structure of a Babesia bovis 44- kilodalton variable merozoite surface antigen. Mol. Biochem. Parasitol. 55:75-83.
136. Florin-Christensen M, Suarez CE, Hines SA, Palmer GH, Brown WC, McElwain TF. 2002. The Babesia bovis merozoite surface antigen 2 locus contains four tandemly arranged and expressed genes encoding immunologically distinct proteins. Infect. Immun. 70:3566-3575.
137. Mosqueda J, McElwain TF, Palmer GH. 2002. Babesia bovis merozoite surface antigen 2 proteins are expressed on the merozoite and sporozoite surface, and specific antibodies inhibit attachment and invasion of erythrocytes. Infect. Immun. 70:6448-6455.
138. Mosqueda J, McElwain TF, Stiller D, Palmer GH. 2002. Babesia bovis merozoite surface antigen 1 and rhoptry-associated protein 1 are expressed in sporozoites, and specific antibodies inhibit sporozoite attachment to erythrocytes. Infect. Immun. 70:1599-1603.
139. Moro MH, David CS, Magera JM, Wettstein PJ, Barthold SW, Persing DH. 1998. Differential effects of infection with a Babesia-like piroplasm, WA1, in inbred mice. Infect. Immun. 66:492-498.
140. Li Y, Terkawi MA, Nishikawa Y, Aboge GO, Luo Y, Ooka H, Goo YK, Yu L, Cao S, Sun Y, Yamagishi J, Masatani T, Yokoyama N, Igarashi I, Xuan X. 2012. Macrophages are critical for cross-protective immunity conferred by Babesia microti against Babesia rodhaini infection in mice. Infect. Immun. 80:311-320.
141. Goff WL, Johnson WC, Parish SM, Barrington GM, Tuo W, Valdez RA. 2001. The age-related immunity in cattle to Babesia bovis infection involves the rapid induction of interleukin-12, interferon-gamma and inducible nitric oxide synthase mRNA expression in the spleen. Parasite Immunol. 23:463-471.
142. Leiby DA. 2011. Transfusion-transmitted Babesia spp.: bull's-eye on Babesia microti. Clin. Microbiol. Rev. 24:14-28.
143. M'Fadyean J, Schein E. 1911. A new species of piroplasm found in the blood of British cattle. J. Comp. Pathol. 24:340-354.
144. Garnham PCC, Bray RS. 1959. The susceptibility of the higher primates to piroplasms. J. Protozool. 6:352-355.
145. Garnham PCC, Voller A. 1965. Experimental studies on Babesia divergens in rhesus monkeys with special reference to its diagnosis by serologic methods. Acta Protozool. 3:183-187.
146. Lewis D, Williams H. 1979. Infection of the Mongolian gerbil with the cattle piroplasm Babesia divergens. Nature 278:170-171.
147. Lewis D, Young ER, Baggott DG, Osborn GD. 1981. Babesia divergens infection of the Mongolian gerbil: titration of infective dose and preliminary observations on the disease produced. J. Comp. Pathol. 91:565-572.
148. Homer MJ, Aguilar-Delfin I, Telford SR, III, Krause PJ, Persing DH. 2000. Babesiosis. Clin. Microbiol. Rev. 13:451-469.
149. Zintl A, Mulcahy G, Skerrett HE, Taylor SM, Gray JS. 2003. Babesia divergens, a bovine blood parasite of veterinary and zoonotic importance. Clin. Microbiol. Rev. 16:622-636.
150. Martinot M, Zadeh MM, Hansmann Y, Grawey I, Christmann D, Aguillon S, Jouglin M, Chauvin A, De Briel D. 2011. Babesiosis in immunocompetent patients, Europe. Emerg. Infect. Dis. 17:114-116.
151. Hunfeld KP, Allwinn R, Peters S, Kraiczy P, Brade V. 1998. Serologic evidence for tick-borne pathogens other than Borrelia burgdorferi (TOBB) in Lyme borreliosis patients from midwestern Germany. Wien. Klin. Wochenschr. 110:901-908.
152. Bastian S, Jouglin M, Brisseau N, Malandrin L, Klegou G, L'Hostis M, Chauvin A. 2012. Antibody prevalence and molecular identification of Babesia spp. in roe deer in France. J. Wildl. Dis. 48:416-424.
153. Goethert HK, Telford SR, III. 2003. Enzootic transmission of Babesia divergens among cottontail rabbits on Nantucket Island, Massachusetts. Am. J. Trop. Med. Hyg. 69:455-460.
154. Kjemtrup AM, Thomford J, Robinson T, Conrad PA. 2000. Phylogenetic relationships of human and wildlife piroplasm isolates in the western United States inferred from the 18S nuclear small subunit RNA gene. Parasitology 120(Part 5):487-493.
155. Conrad PA, Kjemtrup AM, Carreno RA, Thomford J, Wainwright K, Eberhard M, Quick R, Telford SR, III, Herwaldt BL. 2006. Description of Babesia duncani n. sp. (Apicomplexa: Babesiidae) from humans and its differentiation from other piroplasms. Int. J. Parasitol. 36:779-789.
156. Kjemtrup AM, Wainwright K, Miller M, Penzhorn BL, Carreno RA. 2006. Babesia conradae, sp. nov., a small canine Babesia identified in California. Vet. Parasitol. 138:103-111.
157. Herwaldt BL, Linden JV, Bosserman E, Young C, Olkowska D, Wilson M. 2011. Transfusion-associated babesiosis in the United States: a description of cases. Ann. Intern. Med. 155:509-519.
158. Sethi S, Alcid D, Kesarwala H, Tolan RW, Jr. 2009. Probable congenital babesiosis in infant, New Jersey, USA. Emerg. Infect. Dis. 15:788-791.
159. Aderinboye O, Syed SS. 2010. Congenital babesiosis in a four-week-old female infant. Pediatr. Infect. Dis. J. 29:188. doi:10.1097/INF.0b013e3181c36eb9.
160. Joseph JT, Purtill K, Wong SJ, Munoz J, Teal A, Madison-Antenucci S, Horowitz HW, Aguero-Rosenfeld ME, Moore JM, Abramowsky C, Wormser GP. 2012. Vertical transmission of Babesia microti, United States. Emerg. Infect. Dis. 18:1318-1321.
161. New DL, Quinn JB, Qureshi MZ, Sigler SJ. 1997. Vertically transmitted babesiosis. J. Pediatr. 131:163-164.
162. Esernio-Jenssen D, Scimeca PG, Benach JL, Tenenbaum MJ. 1987. Transplacental/perinatal babesiosis. J. Pediatr. 110:570-572.
163. Grabowski EF, Giardina PJ, Goldberg D, Masur H, Read SE, Hirsch RL, Benach JL. 1982. Babesiosis transmitted by a transfusion of frozenthawed blood. Ann. Intern. Med. 96:466-467.
164. Yabsley MJ, Davidson WR, Stallknecht DE, Varela AS, Swift PK, Devos JC, Jr, Dubay SA. 2005. Evidence of tick-borne organisms in mule deer (Odocoileus hemionus) from the western United States. Vector Borne Zoonotic Dis. 5:351-362.
165. Chagas C. 1909. Nova tripanosomiaze humana. Estudos sobre morfolojia e o ciclo evolutivo do Schizotrypanum cruzi n.g., n. sp., ajente etiologico de nova entidade morbida do homen. Mem. Inst. Oswaldo Cruz 1:159-218.
166. World Health Organization. 2008. The global burden of disease: 2004 update. WHO Press, Geneva, Switzerland.
167. Teixeira AR, Hecht MM, Guimaro MC, Sousa AO, Nitz N. 2011. Pathogenesis of Chagas' disease: parasite persistence and autoimmunity. Clin. Microbiol. Rev. 24:592-630.
168. Padilla AM, Bustamante JM, Tarleton RL. 2009. CD8+ T cells in Trypanosoma cruzi infection. Curr. Opin. Immunol. 21:385-390.
169. Caradonna KL, Burleigh BA. 2011. Mechanisms of host cell invasion by Trypanosoma cruzi. Adv. Parasitol. 76:33-61.
170. El-Sayed NM, Myler PJ, Bartholomeu DC, Nilsson D, Aggarwal G, Tran AN, Ghedin E, Worthey EA, Delcher AL, Blandin G, Westenberger SJ, Caler E, Cerqueira GC, Branche C, Haas B, Anupama A, Arner E, Aslund L, Attipoe P, Bontempi E, Bringaud F, Burton P, Cadag E, Campbell DA, Carrington M, Crabtree J, Darban H, DA Silveira JF, de Jong P, Edwards K, Englund PT, Fazelina G, Feldblyum T, Ferella M, Frasch AC, Gull K, Horn D, Hou L, Huang Y, Kindlund E, Klingbeil M, Kluge S, Koo H, Lacerda D, Levin MJ, Lorenzi H, Louie T, Machado CR, McCulloch R, McKenna A, Mizuno Y, Mottram JC, Nelson S, Ochaya S, Osoegawa K, Pai G, Parsons M, Pentony M, Pettersson U, Pop M, Ramirez JL, Rinta J, Robertson L, Salzberg SL, Sanchez DO, Seyler A, Sharma R, Shetty J, Simpson AJ, Sisk E, Tammi MT, Tarleton R, Teixeira S, Van Aken S, Vogt C, Ward PN, Wickstead B, Wortman J, White O, Fraser CM, Stuart KD, Andersson B. 2005. The genome sequence of Trypanosoma cruzi, etiologic agent of Chagas disease. Science 309:409-415.
171. Padilla AM, Simpson LJ, Tarleton RL. 2009. Insufficient TLR activation contributes to the slow development of CD8+ T cell responses in Trypanosoma cruzi infection. J. Immunol. 183:1245-1252.
172. Nagajyothi F, Weiss LM, Silver DL, Desruisseaux MS, Scherer PE, Herz J, Tanowitz HB. 2011. Trypanosoma cruzi utilizes the host low density lipoprotein receptor in invasion. PLoS Negl. Trop. Dis. 5:e953. doi:10.1371/journal.pntd.0000953.
173. Woolsey AM, Sunwoo L, Petersen CA, Brachmann SM, Cantley LC, Burleigh BA. 2003. Novel PI 3-kinase-dependent mechanisms of trypanosome invasion and vacuole maturation. J. Cell Sci. 116:3611-3622.
174. Ley V, Robbins ES, Nussenzweig V, Andrews NW. 1990. The exit of Trypanosoma cruzi from the phagosome is inhibited by raising the pH of acidic compartments. J. Exp. Med. 171:401-413.
175. Andrews NW, Whitlow MB. 1989. Secretion by Trypanosoma cruzi of a hemolysin active at low pH. Mol. Biochem. Parasitol. 33:249-256.
176. Hall BF, Webster P, Ma AK, Joiner KA, Andrews NW. 1992. Desialylation of lysosomal membrane glycoproteins by Trypanosoma cruzi: a role for the surface neuraminidase in facilitating parasite entry into the host cell cytoplasm. J. Exp. Med. 176:313-325.
177. Andrade LO, Andrews NW. 2004. Lysosomal fusion is essential for the retention of Trypanosoma cruzi inside host cells. J. Exp. Med. 200:1135-1143.
178. Campos MA, Almeida IC, Takeuchi O, Akira S, Valente EP, Procopio DO, Travassos LR, Smith JA, Golenbock DT, Gazzinelli RT. 2001. Activation of Toll-like receptor-2 by glycosylphosphatidylinositol anchors from a protozoan parasite. J. Immunol. 167:416-423.
179. Oliveira AC, Peixoto JR, de Arruda LB, Campos MA, Gazzinelli RT, Golenbock DT, Akira S, Previato JO, Mendonca-Previato L, Nobrega A, Bellio M. 2004. Expression of functional TLR4 confers proinflammatory responsiveness to Trypanosoma cruzi glycoinositolphospholipids and higher resistance to infection with T. cruzi. J. Immunol. 173:5688-5696.
180. Bartholomeu DC, Ropert C, Melo MB, Parroche P, Junqueira CF, Teixeira SM, Sirois C, Kasperkovitz P, Knetter CF, Lien E, Latz E, Golenbock DT, Gazzinelli RT. 2008. Recruitment and endo-lysosomal activation of TLR9 in dendritic cells infected with Trypanosoma cruzi. J. Immunol. 181:1333-1344.
181. Bafica A, Santiago HC, Goldszmid R, Ropert C, Gazzinelli RT, Sher A. 2006. TLR9 and TLR2 signaling together account for MyD88-dependent control of parasitemia in Trypanosoma cruzi infection. J. Immunol. 177: 3515-3519.
182. Caetano BC, Carmo BB, Melo MB, Cerny A, dos Santos SL, Bartholomeu DC, Golenbock DT, Gazzinelli RT. 2011. Requirement of UNC93B1 reveals a critical role for TLR7 in host resistance to primary infection with Trypanosoma cruzi. J. Immunol. 187:1903-1911.
183. Rodriguez AM, Santoro F, Afchain D, Bazin H, Capron A. 1981. Trypanosoma cruzi infection in B-cell-deficient rats. Infect. Immun. 31: 524-529.
184. Takehara HA, Perini A, da Silva MH, Mota I. 1981. Trypanosoma cruzi: role of different antibody classes in protection against infection in the mouse. Exp. Parasitol. 52:137-146.
185. Kirchhoff LV. 2011. Epidemiology of American trypanosomiasis (Chagas disease). Adv. Parasitol. 75:1-18.
186. Araujo A, Jansen AM, Reinhard K, Ferreira LF. 2009. Paleoparasitology of Chagas disease-a review. Mem. Inst. Oswaldo Cruz 104(Suppl 1):9-16.
187. Miles MA, Feliciangeli MD, de Arias MR. 2003. American trypanosomiasis (Chagas' disease) and the role of molecular epidemiology in guiding control strategies. BMJ 326:1444-1448.
188. Bern C, Kjos S, Yabsley MJ, Montgomery SP. 2011. Trypanosoma cruzi and Chagas' disease in the United States. Clin. Microbiol. Rev. 24:655-681.
189. Cantey PT, Stramer SL, Townsend RL, Kamel H, Ofafa K, Todd CW, Currier M, Hand S, Varnado W, Dotson E, Hall C, Jett PL, Montgomery SP. 2012. The United States Trypanosoma cruzi Infection Study: evidence for vector-borne transmission of the parasite that causes Chagas disease among United States blood donors. Transfusion 52:1922-1930.
190. Bonfante-Cabarcas R, Rodriguez-Bonfante C, Vielma BO, Garcia D, Saldivia AM, Aldana E, Curvelo JL. 2011. Seroprevalence for Trypanosoma cruzi infection and associated factors in an endemic area of Venezuela. Cad. Saude Publica 27:1917-1929. (In Spanish.)
191. King RJ, Cordon-Rosales C, Cox J, Davies CR, Kitron UD. 2011. Triatoma dimidiata infestation in Chagas disease endemic regions of Guatemala: comparison of random and targeted cross-sectional surveys. PLoS Negl. Trop. Dis. 5:e1035. doi:10.1371/journal.pntd.0001035.
192. Gurevitz JM, Ceballos LA, Gaspe MS, Alvarado-Otegui JA, Enriquez GF, Kitron U, Gurtler RE. 2011. Factors affecting infestation by Triatoma infestans in a rural area of the humid Chaco in Argentina: a multimodel inference approach. PLoS Negl. Trop. Dis. 5:e1349. doi:10.1371/journal.pntd.0001349.
193. Bowman NM, Kawai V, Gilman RH, Bocangel C, Galdos-Cardenas G, Cabrera L, Levy MZ, Cornejo del Carpio JG, Delgado F, Rosenthal L, Pinedo-Cancino VV, Steurer F, Seitz AE, Maguire JH, Bern C. 2011. Autonomic dysfunction and risk factors associated with Trypanosoma cruzi infection among children in Arequipa, Peru. Am. J. Trop. Med. Hyg. 84:85-90.
194. Gurtler RE, Ceballos LA, Ordonez-Krasnowski P, Lanati LA, Stariolo R, Kitron U. 2009. Strong host-feeding preferences of the vector Triatoma infestans modified by vector density: implications for the epidemiology of Chagas disease. PLoS Negl. Trop. Dis. 3:e447. doi:10.1371/journal.pntd.0000447.
195. Kjos SA, Snowden KF, Craig TM, Lewis B, Ronald N, Olson JK. 2008. Distribution and characterization of canine Chagas disease in Texas. Vet. Parasitol. 152:249-256.
196. Gurtler RE, Cohen JE, Cecere MC, Lauricella MA, Chuit R, Segura EL. 1998. Influence of humans and domestic animals on the household prevalence of Trypanosoma cruzi in Triatoma infestans populations in northwest Argentina. Am. J. Trop. Med. Hyg. 58:748-758.
197. Gurtler RE, Cecere MC, Lauricella MA, Cardinal MV, Kitron U, Cohen JE. 2007. Domestic dogs and cats as sources of Trypanosoma cruzi infection in rural northwestern Argentina. Parasitology 134:69-82.
198. Pineda V, Saldana A, Monfante I, Santamaria A, Gottdenker NL, Yabsley MJ, Rapoport G, Calzada JE. 2011. Prevalence of trypanosome infections in dogs from Chagas disease endemic regions in Panama, Central America. Vet. Parasitol. 178:360-363.
199. Balan LU, Yerbes IM, Pina MA, Balmes J, Pascual A, Hernandez O, Lopez R, Monteon V. 2011. Higher seroprevalence of Trypanosoma cruzi infection in dogs than in humans in an urban area of Campeche, Mexico. Vector Borne Zoonotic Dis. 11:843-844.
200. Bern C, Martin DL, Gilman RH. 2011. Acute and congenital Chagas disease. Adv. Parasitol. 75:19-47.
201. Romero M, Postigo J, Schneider D, Chippaux JP, Santalla JA, Brutus L. 2011. Door-to-door screening as a strategy for the detection of congenital Chagas disease in rural Bolivia. Trop. Med. Int. Health 16:562-569.
202. Brutus L, Castillo H, Bernal C, Salas NA, Schneider D, Santalla JA, Chippaux JP. 2010. Detectable Trypanosoma cruzi parasitemia during pregnancy and delivery as a risk factor for congenital Chagas disease. Am. J. Trop. Med. Hyg. 83:1044-1047.
203. Bern C, Verastegui M, Gilman RH, Lafuente C, Galdos-Cardenas G, Calderon M, Pacori J, Del Carmen Abastoflor M, Aparicio H, Brady MF, Ferrufino L, Angulo N, Marcus S, Sterling C, Maguire JH. 2009. Congenital Trypanosoma cruzi transmission in Santa Cruz, Bolivia. Clin. Infect. Dis. 49:1667-1674.
204. Cardoso EJ, Valdez GC, Campos AC, Sanchez RD, Mendoza CR, Hernandez AP, Ramirez MH, Habana JR, Gonzalez EB, Matzumura PD, Carlier Y. 2012. Maternal fetal transmission of Trypanosoma cruzi: a problem of public health little studied in Mexico. Exp. Parasitol. 131: 425-432.
205. Torrico F, Alonso-Vega C, Suarez E, Rodriguez P, Torrico MC, Dramaix M, Truyens C, Carlier Y. 2004. Maternal Trypanosoma cruzi infection, pregnancy outcome, morbidity, and mortality of congenitally infected and non-infected newborns in Bolivia. Am. J. Trop. Med. Hyg. 70:201-209.
206. Barona-Vilar C, Gimenez-Marti MJ, Fraile T, Gonzalez-Steinbauer C, Parada C, Gil-Brusola A, Bravo D, Gomez MD, Navarro D, Perez- Tamarit A, Fernandez-Silveira L, Fullana-Montoro A, Borras R. 2011. Prevalence of Trypanosoma cruzi infection in pregnant Latin American women and congenital transmission rate in a non-endemic area: the experience of the Valencian Health Programme (Spain). Epidemiol. Infect. 140:1896-1903.
207. Lazarte RA, Litman-Mazo F, Crewalk Keim J-ADE, Baram M, Klassen- Fischer MK, Massif D, Zabielski ML, Sockwell D, Kurkjian K, Moore A, Qvarnstrom Y, Steurer F. 2012. Congenital transmission of Chagas disease-Virginia, 2010.MMWRMorb. Mortal. Wkly. Rep. 61:477-479.
208. Yadon ZE, Schmunis GA. 2009. Congenital Chagas disease: estimating the potential risk in the United States. Am. J. Trop. Med. Hyg. 81:927-933.
209. Wendel S. 2010. Transfusion transmitted Chagas disease: is it really under control? Acta Trop. 115:28-34.
210. Cimo PL, Luper WE, Scouros MA. 1993. Transfusion-associated Chagas' disease in Texas: report of a case. Tex. Med. 89:48-50.
211. Centers for Disease Control and Prevention. 2002. Chagas disease after organ transplantation-United States, 2001. MMWR Morb. Mortal. Wkly. Rep. 51:210-212.
212. Kun H, Moore A, Mascola L, Steurer F, Lawrence G, Kubak B, Radhakrishna S, Leiby D, Herron R, Mone T, Hunter R, Kuehnert M. 2009. Transmission of Trypanosoma cruzi by heart transplantation. Clin. Infect. Dis. 48:1534-1540.
213. Grant IH, Gold JW, Wittner M, Tanowitz HB, Nathan C, Mayer K, Reich L, Wollner N, Steinherz L, Ghavimi F, O'Reilly RJ, Armstrong D. 1989. Transfusion-associated acute Chagas disease acquired in the United States. Ann. Intern. Med. 111:849-851.
214. Leiby DA, Lenes BA, Tibbals MA, Tames-Olmedo MT. 1999. Prospective evaluation of a patient with Trypanosoma cruzi infection transmitted by transfusion. N. Engl. J. Med. 341:1237-1239.
215. Young C, Losikoff P, Chawla A, Glasser L, Forman E. 2007. Transfusion- acquired Trypanosoma cruzi infection. Transfusion 47:540-544.
216. Chagas Biovigilance Network. 28 June 2012, posting date. Chagas biovigilance: RIPA positive map. AABB, Bethesda, MD. http://www.aabb.org/programs/biovigilance/Pages/chagas.aspx#1.
217. Davis DS, Russell LH, Adams LG, Yaeger RG, Robinson RM. 1980. An experimental infection of Trypanosoma cruzi in striped skunks (Mephitis mephitis). J. Wildl. Dis. 16:403-406.
218. Roellig DM, Ellis AE, Yabsley MJ. 2009. Oral transmission of Trypanosoma cruzi with opposing evidence for the theory of carnivory. J. Parasitol. 95:360-364.
219. Shikanai-Yasuda MA, Carvalho NB. 2012. Oral transmission of Chagas disease. Clin. Infect. Dis. 54:845-852.
220. Pereira KS, Schmidt FL, Guaraldo AM, Franco RM, Dias VL, Passos LA. 2009. Chagas' disease as a foodborne illness. J. Food Prot. 72:441-446.
221. Alarcon de Noya B, Diaz-Bello Z, Colmenares C, Ruiz-Guevara R, Mauriello L, Zavala-Jaspe R, Suarez JA, Abate T, Naranjo L, Paiva M, Rivas L, Castro J, Marques J, Mendoza I, Acquatella H, Torres J, Noya O. 2010. Large urban outbreak of orally acquired acute Chagas disease at a school in Caracas, Venezuela. J. Infect. Dis. 201:1308-1315.
222. Borges JD, Assis GF, Gomes LV, Dias JC, Pinto ID, Martins-Filho OA, Torres RM, Vinas PA, Bahia MT, Machado-Coelho GL, Lana M. 2006. Seroprevalence of Chagas disease in schoolchildren from two municipalities of Jequitinhonha Valley, Minas Gerais, Brazil; six years following the onset of epidemiological surveillance. Rev. Inst. Med. Trop. Sao Paulo 48:81-86.
223. Segura EL, Cura EN, Estani SA, Andrade J, Lansetti JC, de Rissio AM, Campanini A, Blanco SB, Gurtler RE, Alvarez M. 2000. Long-term effects of a nationwide control program on the seropositivity for Trypanosoma cruzi infection in young men from Argentina. Am. J. Trop. Med. Hyg. 62:353-362.
224. Carlier Y, Torrico F, Sosa-Estani S, Russomando G, Luquetti A, Freilij H, Albajar Vinas P. 2011. Congenital Chagas disease: recommendations for diagnosis, treatment and control of newborns, siblings and pregnant women. PLoS Negl. Trop. Dis. 5:e1250. doi:10.1371/journal.pntd.0001250.
225. Magill AJ, Grogl M, Gasser RA, Jr, Sun W, Oster CN. 1993. Visceral infection caused by Leishmania tropica in veterans of Operation Desert Storm. N. Engl. J. Med. 328:1383-1387.
226. Morsy TA, Schnur LF, Feinsod FM, Salem AM, Wahba MM, el Said SM. 1987. Natural infections of Leishmania major in domestic dogs from Alexandria, Egypt. Am. J. Trop. Med. Hyg. 37:49-52.
227. Akhavan AA, Yaghoobi-Ershadi MR, Khamesipour A, Mirhendi H, Alimohammadian MH, Rassi Y, Arandian MH, Jafari R, Abdoli H, Shareghi N, Ghanei M, Jalali-zand N. 2010. Dynamics of Leishmania infection rates in Rhombomys opimus (Rodentia: Gerbillinae) population of an endemic focus of zoonotic cutaneous leishmaniasis in Iran. Bull. Soc. Pathol. Exot. 103:84-89.
228. Azizi K, Moemenbellah-Fard MD, Fakoorziba MR, Fekri S. 2011. Gerbillus nanus (Rodentia: Muridae): a new reservoir host of Leishmania major. Ann. Trop. Med. Parasitol. 105:431-437.
229. Ghawar W, Toumi A, Snoussi MA, Chlif S, Zaatour A, Boukthir A, Hamida NB, Chemkhi J, Diouani MF, Ben-Salah A. 2011. Leishmania major infection among Psammomys obesus and Meriones shawi: reservoirs of zoonotic cutaneous leishmaniasis in Sidi Bouzid (central Tunisia). Vector Borne Zoonotic Dis. 11:1561-1568.
230. Toumi A, Chlif S, Bettaieb J, Ben Alaya N, Boukthir A, Ahmadi ZE, Ben Salah A. 2012. Temporal dynamics and impact of climate factors on the incidence of zoonotic cutaneous leishmaniasis in central Tunisia. PLoS Negl. Trop. Dis. 6:e1633. doi:10.1371/journal.pntd.0001633.
231. Wasserberg G, Abramsky Z, Anders G, El-Fari M, Schoenian G, Schnur L, Kotler BP, Kabalo I, Warburg A. 2002. The ecology of cutaneous leishmaniasis in Nizzana, Israel: infection patterns in the reservoir host, and epidemiological implications. Int. J. Parasitol. 32:133-143.
232. Yavar R, Abedin S, Reza AM, Ali OM, Sina R, Mehdi M, Reza YE, Fatemeh M, Babak F. 2011. Phlebotomus papatasi and Meriones libycus as the vector and reservoir host of cutaneous leishmaniasis in Qomrood District, Qom Province, central Iran. Asian Pac. J. Trop. Med. 4:97-100.
233. Elbihari S, Cheema AH, el-Hassan AM. 1987. Leishmania infecting man and wild animals in Saudi Arabia. 4. Canine cutaneous leishmaniasis in the Eastern Province. Trans. R. Soc. Trop. Med. Hyg. 81:925-927.
234. Gebre-Michael T, Balkew M, Ali A, Ludovisi A, Gramiccia M. 2004. The isolation of Leishmania tropica and L. aethiopica from Phlebotomus (Paraphlebotomus) species (Diptera: Psychodidae) in the Awash Valley, northeastern Ethiopia. Trans. R. Soc. Trop. Med. Hyg. 98:64-70.
235. Lemma W, Erenso G, Gadisa E, Balkew M, Gebre-Michael T, Hailu A. 2009. A zoonotic focus of cutaneous leishmaniasis in Addis Ababa, Ethiopia. Parasit. Vectors 2:60. doi:10.1186/1756-3305-2-60.
236. Trainor KE, Porter BF, Logan KS, Hoffman RJ, Snowden KF. 2010. Eight cases of feline cutaneous leishmaniasis in Texas. Vet. Pathol. 47: 1076-1081.
237. Wright NA, Davis LE, Aftergut KS, Parrish CA, Cockerell CJ. 2008. Cutaneous leishmaniasis in Texas: a northern spread of endemic areas. J. Am. Acad. Dermatol. 58:650-652.
238. Kerr SF, McHugh CP, Dronen NO, Jr. 1995. Leishmaniasis in Texas: prevalence and seasonal transmission of Leishmania mexicana in Neotoma micropus. Am. J. Trop. Med. Hyg. 53:73-77.
239. Van Wynsberghe NR, Canto-Lara SB, Sosa-Bibiano EI, Rivero- Cardenas NA, Andrade-Narvaez FJ. 2009. Comparison of small mammal prevalence of Leishmania (Leishmania) mexicana in five foci of cutaneous leishmaniasis in the State of Campeche, Mexico. Rev. Inst. Med. Trop. Sao Paulo 51:87-94.
240. Arjona-Jimenez G, Villegas N, Lopez-Cespedes A, Marin C, Longoni SS, Bolio-Gonzalez ME, Rodriguez-Vivas RI, Sauri-Arceo CH, Sanchez- Moreno M. 2012. Prevalence of antibodies against three species of Leishmania (L. mexicana, L. braziliensis, L. infantum) and possible associated factors in dogs from Merida, Yucatan, Mexico. Trans. R. Soc. Trop. Med. Hyg. 106:252-258.
241. Longoni SS, Lopez-Cespedes A, Sanchez-Moreno M, Bolio-Gonzalez ME, Sauri-Arceo CH, Rodriguez-Vivas RI, Marin C. 2012. Detection of different Leishmania spp. and Trypanosoma cruzi antibodies in cats from the Yucatan Peninsula (Mexico) using an iron superoxide dismutase excreted as antigen. Comp. Immunol. Microbiol. Infect. Dis. 35: 469-476.
242. Telleria J, Bosseno MF, Tarifa T, Buitrago R, Martinez E, Torrez M, Le Pont F, Breniere SF. 1999. Putative reservoirs of Leishmania amazonensis in a sub-Andean focus of Bolivia identified by kDNA-polymerase chain reaction. Mem. Inst. Oswaldo Cruz 94:5-6.
243. Tolezano JE, Uliana SR, Taniguchi HH, Araujo MF, Barbosa JA, Barbosa JE, Floeter-Winter LM, Shaw JJ. 2007. The first records of Leishmania (Leishmania) amazonensis in dogs (Canis familiaris) diagnosed clinically as having canine visceral leishmaniasis from Aracatuba County, Sao Paulo State, Brazil. Vet. Parasitol. 149:280-284.
244. Guessous-Idrissi N, Berrag B, Riyad M, Sahibi H, Bichichi M, Rhalem A. 1997. Leishmania tropica: etiologic agent of a case of canine visceral leishmaniasis in northern Morocco. Am. J. Trop. Med. Hyg. 57:172-173.
245. Dereure J, Rioux JA, Gallego M, Perieres J, Pratlong F, Mahjour J, Saddiki H. 1991. Leishmania tropica in Morocco: infection in dogs. Trans. R. Soc. Trop. Med. Hyg. 85:595.
246. Jacobson RL, Eisenberger CL, Svobodova M, Baneth G, Sztern J, Carvalho J, Nasereddin A, El Fari M, Shalom U, Volf P, Votypka J, Dedet JP, Pratlong F, Schonian G, Schnur LF, Jaffe CL, Warburg A. 2003. Outbreak of cutaneous leishmaniasis in northern Israel. J. Infect. Dis. 188:1065-1073.
247. Talmi-Frank D, Kedem-Vaanunu N, King R, Bar-Gal GK, Edery N, Jaffe CL, Baneth G. 2010. Leishmania tropica infection in golden jackals and red foxes, Israel. Emerg. Infect. Dis. 16:1973-1975.
248. Mohebali M, Hajjaran H, Hamzavi Y, Mobedi I, Arshi S, Zarei Z, Akhoundi B, Naeini KM, Avizeh R, Fakhar M. 2005. Epidemiological aspects of canine visceral leishmaniosis in the Islamic Republic of Iran. Vet. Parasitol. 129:243-251.
249. Schallig HD, da Silva ES, van der Meide WF, Schoone GJ, Gontijo CM. 2007. Didelphis marsupialis (common opossum): a potential reservoir host for zoonotic leishmaniasis in the metropolitan region of Belo Horizonte (Minas Gerais, Brazil). Vector Borne Zoonotic Dis. 7:387-393.
250. Quaresma PF, Rego FD, Botelho HA, da Silva SR, Moura Junior AJ, Teixeira Neto RG, Madeira FM, Carvalho MB, Paglia AP, Melo MN, Gontijo CM. 2011. Wild, synanthropic and domestic hosts of Leishmania in an endemic area of cutaneous leishmaniasis in Minas Gerais State, Brazil. Trans. R. Soc. Trop. Med. Hyg. 105:579-585.
251. Aguilar CM, Rangel EF, Garcia L, Fernandez E, Momen H, Grimaldi Filho G, De Vargas Z. 1989. Zoonotic cutaneous leishmaniasis due to Leishmania (Viannia) braziliensis associated with domestic animals in Venezuela and Brazil. Mem. Inst. Oswaldo Cruz 84:19-28.
252. Dantas-Torres F. 2007. The role of dogs as reservoirs of Leishmania parasites, with emphasis on Leishmania (Leishmania) infantum and Leishmania (Viannia) braziliensis. Vet. Parasitol. 149:139-146.
253. Christensen HA, Arias JR, de Vasquez AM, de Freitas RA. 1982. Hosts of sandfly vectors of Leishmania braziliensis guyanensis in the central Amazon of Brazil. Am. J. Trop. Med. Hyg. 31:239-242.
254. Santaella J, Ocampo CB, Saravia NG, Mendez F, Gongora R, Gomez MA, Munstermann LE, Quinnell RJ. 2011. Leishmania (Viannia) infection in the domestic dog in Chaparral, Colombia. Am. J. Trop. Med. Hyg. 84:674-680.
255. Llanos-Cuentas EA, Roncal N, Villaseca P, Paz L, Ogusuku E, Perez JE, Caceres A, Davies CR. 1999. Natural infections of Leishmania peruviana in animals in the Peruvian Andes. Trans. R. Soc. Trop. Med. Hyg. 93:15-20.
256. Lainson R, Braga RR, De Souza AA, Povoa MM, Ishikawa EA, Silveira FT. 1989. Leishmania (Viannia) shawi sp. n., a parasite of monkeys, sloths and procyonids in Amazonian Brazil. Ann. Parasitol. Hum. Comp. 64:200-207.
257. Lainson R, Shaw JJ, Souza AA, Silveira FT, Falqueto A. 1992. Further observations on Lutzomyia ubiquitalis (Psychodidae: Phlebotominae), the sandfly vector of Leishmania (Viannia) lainsoni. Mem. Inst. Oswaldo Cruz 87:437-439.
258. Lainson R, Shaw JJ. 1989. Leishmania (Viannia) naiffi sp. n., a parasite of the armadillo, Dasypus novemcinctus (L.) in Amazonian Brazil. Ann. Parasitol. Hum. Comp. 64:3-9.
259. Bonfante-Garrido R, Urdaneta I, Urdaneta R, Alvarado J. 1991. Natural infection of cats with Leishmania in Barquisimeto, Venezuela. Trans. R. Soc. Trop. Med. Hyg. 85:53.
260. Dereure J, Espinel I, Barrera C, Guerrini F, Martini A, Echeverria R, Guderian RH, Le Pont F. 1994. Leishmaniasis in Ecuador. 4. Natural infestation of the dog by Leishmania panamensis. Ann. Soc. Belg. Med. Trop. 74:29-33. (In French.)
261. Herrer A, Christensen HA. 1980. Leishmania braziliensis in the Panamanian two-toed sloth, Choloepus hoffmanni. Am. J. Trop. Med. Hyg. 29:1196-1200.
262. Thatcher VE, Eisenmann C, Hertig M. 1965. A natural infection of Leishmania in the kinkajou, Potos flavus, in Panama. J. Parasitol. 51: 1022-1023.
263. Velez ID, Carrillo LM, Lopez L, Rodriguez E, Robledo SM. 2012. An epidemic outbreak of canine cutaneous leishmaniasis in Colombia caused by Leishmania braziliensis and Leishmania panamensis. Am. J. Trop. Med. Hyg. 86:807-811.
264. Herrer A, Christensen HA. 1976. Natural cutaneous leishmaniasis among dogs in Panama. Am. J. Trop. Med. Hyg. 25:59-63.
265. Bhattarai NR, Van der Auwera G, Rijal S, Picado A, Speybroeck N, Khanal B, De Doncker S, Das ML, Ostyn B, Davies C, Coosemans M, Berkvens D, Boelaert M, Dujardin JC. 2010. Domestic animals and epidemiology of visceral leishmaniasis, Nepal. Emerg. Infect. Dis. 16: 231-237.
266. Dereure J, El-Safi SH, Bucheton B, Boni M, Kheir MM, Davoust B, Pratlong F, Feugier E, Lambert M, Dessein A, Dedet JP. 2003. Visceral leishmaniasis in eastern Sudan: parasite identification in humans and dogs; host-parasite relationships. Microbes Infect. 5:1103-1108.
267. Kalayou S, Tadelle H, Bsrat A, Abebe N, Haileselassie M, Schallig HD. 2011. Serological evidence of Leishmania donovani infection in apparently healthy dogs using direct agglutination test (DAT) and rk39 dipstick tests in Kafta Humera, north-west Ethiopia. Transbound. Emerg. Dis. 58:255-262.
268. Sharma NL, Mahajan VK, Negi AK, Verma GK. 2009. The rK39 immunochromatic dipstick testing: a study for K39 seroprevalence in dogs and human leishmaniasis patients for possible animal reservoir of cutaneous and visceral leishmaniasis in endemic focus of Satluj river valley of Himachal Pradesh (India). Indian J. Dermatol. Venereol. Leprol. 75:52-55.
269. Gramiccia M, Gradoni L. 2005. The current status of zoonotic leishmaniases and approaches to disease control. Int. J. Parasitol. 35:1169-1180.
270. Vides JP, Schwardt TF, Sobrinho LS, Marinho M, Laurenti MD, Biondo AW, Leutenegger C, Marcondes M. 2011. Leishmania chagasi infection in cats with dermatologic lesions from an endemic area of visceral leishmaniosis in Brazil. Vet. Parasitol. 178:22-28.
271. Lima ID, Queiroz JW, Lacerda HG, Queiroz PV, Pontes NN, Barbosa JD, Martins DR, Weirather JL, Pearson RD, Wilson ME, Jeronimo SM. 2012. Leishmania infantum chagasi in northeastern Brazil: asymptomatic infection at the urban perimeter. Am. J. Trop. Med. Hyg. 86:99-107.
272. Coura-Vital W, Marques MJ, Veloso VM, Roatt BM, Aguiar-Soares RD, Reis LE, Braga SL, Morais MH, Reis AB, Carneiro M. 2011. Prevalence and factors associated with Leishmania infantum infection of dogs from an urban area of Brazil as identified by molecular methods. PLoS Negl. Trop. Dis. 5:e1291. doi:10.1371/journal.pntd.0001291.
273. Falqueto A, Ferreira AL, dos Santos CB, Porrozzi R, da Costa MV, Teva A, Cupolillo E, Campos-Neto A, Grimaldi G, Jr. 2009. Crosssectional and longitudinal epidemiologic surveys of human and canine Leishmania infantum visceral infections in an endemic rural area of southeast Brazil (Pancas, Espirito Santo). Am. J. Trop. Med. Hyg. 80: 559-565.
274. Martin-Sanchez J, Morales-Yuste M, Acedo-Sanchez C, Baron S, Diaz V, Morillas-Marquez F. 2009. Canine leishmaniasis in southeastern Spain. Emerg. Infect. Dis. 15:795-798.
275. Cortes S, Vaz Y, Neves R, Maia C, Cardoso L, Campino L. 2012. Risk factors for canine leishmaniasis in an endemic Mediterranean region. Vet. Parasitol. 189:189-196.
276. Tabar MD, Altet L, Francino O, Sanchez A, Ferrer L, Roura X. 2008. Vector-borne infections in cats: molecular study in Barcelona area (Spain). Vet. Parasitol. 151:332-336.
277. Molina R, Jimenez MI, Cruz I, Iriso A, Martin-Martin I, Sevillano O, Melero S, Bernal J. 2012. The hare (Lepus granatensis) as potential sylvatic reservoir of Leishmania infantum in Spain. Vet. Parasitol. 190: 268-271.
278. Tenorio MS, Oliveira e Sousa L, Paixao MS, Alves MF, Paulan SC, Lima FL, Jusi MM, Tasca KI, Machado RZ, Starke-Buzetti WA. 2011. Visceral leishmaniasis in a captive crab-eating fox Cerdocyon thous. J. Zoo Wildl. Med. 42:608-616.
279. Jusi MM, Starke-Buzetti WA, Oliveira TM, Tenorio MS, Sousa LO, Machado RZ. 2011. Molecular and serological detection of Leishmania spp. in captive wild animals from Ilha Solteira, SP, Brazil. Rev. Bras. Parasitol. Vet. 20:219-222.
280. Tzamouranis N, Schnur LF, Garifallou A, Pateraki E, Serie C. 1984. Leishmaniasis in Greece. I. Isolation and identification of the parasite causing human and canine visceral leishmaniasis. Ann. Trop. Med. Parasitol. 78:363-368.
281. Maia C, Gomes J, Cristovao J, Nunes M, Martins A, Rebelo E, Campino L. 2010. Feline Leishmania infection in a canine leishmaniasis endemic region, Portugal. Vet. Parasitol. 174:336-340.
282. Cardoso L, Lopes AP, Sherry K, Schallig H, Solano-Gallego L. 2010. Low seroprevalence of Leishmania infantum infection in cats from northern Portugal based on DAT and ELISA. Vet. Parasitol. 174:37-42.
283. Sherry K, Miro G, Trotta M, Miranda C, Montoya A, Espinosa C, Ribas F, Furlanello T, Solano-Gallego L. 2011. A serological and molecular study of Leishmania infantum infection in cats from the Island of Ibiza (Spain). Vector Borne Zoonotic Dis. 11:239-245.
284. Hatam GR, Adnani SJ, Asgari Q, Fallah E, Motazedian MH, Sadjjadi SM, Sarkari B. 2010. First report of natural infection in cats with Leishmania infantum in Iran. Vector Borne Zoonotic Dis. 10:313-316.
285. Nasereddin A, Salant H, Abdeen Z. 2008. Feline leishmaniasis in Jerusalem: serological investigation. Vet. Parasitol. 158:364-369.
286. Coelho WM, do Amarante AF, Apolinario JC, Coelho NM, de Lima VM, Perri SH, Bresciani KD. 2011. Seroepidemiology of Toxoplasma gondii, Neospora caninum, and Leishmania spp. infections and risk factors for cats from Brazil. Parasitol. Res. 109:1009-1013.
287. Cardoso L, Mendao C, Madeira de Carvalho L. 2012. Prevalence of Dirofilaria immitis, Ehrlichia canis, Borrelia burgdorferi sensu lato, Anaplasma spp. and Leishmania infantum in apparently healthy and CVBDsuspect dogs in Portugal-a national serological study. Parasit. Vectors 5:62. doi:10.1186/1756-3305-5-62.
288. Athanasiou LV, Kontos VI, Saridomichelakis MN, Rallis TS, Diakou A. 2012. A cross-sectional sero-epidemiological study of canine leishmaniasis in Greek mainland. Acta Trop. 122:291-295.
289. Kovalenko DA, Nasyrova RM, Ponomareva VI, Fatullaeva AA, Razakov SA, Ponirovskii EN, Strelkova MV, Zhirenkina EN, Morozov EN, Dzhaf C, Banet G, Shnur L, Varburg A, Shonian G. 2011. Human and canine visceral leishmaniasis in the Papsky District, Namangan Region, Uzbekistan: seroepidemiological and seroepizootological surveys. Med. Parazitol. (Mosk.) 2011:32-37. (In Russian.)
290. Shang LM, Peng WP, Jin HT, Xu D, Zhong NN, Wang WL, Wu YX, Liu Q. 2011. The prevalence of canine Leishmania infantum infection in Sichuan Province, southwestern China detected by real time PCR. Parasit. Vectors 4:173. doi:10.1186/1756-3305-4-173.
291. Sousa S, Lopes AP, Cardoso L, Silvestre R, Schallig H, Reed SG, Cordeiro da Silva A. 2011. Seroepidemiological survey of Leishmania infantum infection in dogs from northeastern Portugal. Acta Trop. 120: 82-87.
292. Faye B, Banuls AL, Bucheton B, Dione MM, Bassanganam O, Hide M, Dereure J, Choisy M, Ndiaye JL, Konate O, Claire M, Senghor MW, Faye MN, Sy I, Niang AA, Molez JF, Victoir K, Marty P, Delaunay P, Knecht R, Mellul S, Diedhiou S, Gaye O. 2010. Canine visceral leishmaniasis caused by Leishmania infantum in Senegal: risk of emergence in humans? Microbes Infect. 12:1219-1225.
293. Baldelli R, Battelli G, Maroli M, Mollicone E, Gudi A, Stegagno G, Tasini G. 2001. A new stable focus of canine leishmaniasis in northern Italy. Parassitologia 43:151-153.
294. Ozensoy Toz S, Sakru N, Ertabaklar H, Demir S, Sengul M, Ozbel Y. 2009. Serological and entomological survey of zoonotic visceral leishmaniasis in Denizli Province, Aegean Region, Turkey. New Microbiol. 32:93-100.
295. Lemesre JL, Holzmuller P, Goncalves RB, Bourdoiseau G, Hugnet C, Cavaleyra M, Papierok G. 2007. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial. Vaccine 25:4223-4234.
296. Ives A, Ronet C, Prevel F, Ruzzante G, Fuertes-Marraco S, Schutz F, Zangger H, Revaz-Breton M, Lye LF, Hickerson SM, Beverley SM, Acha-Orbea H, Launois P, Fasel N, Masina S. 2011. Leishmania RNA virus controls the severity of mucocutaneous leishmaniasis. Science 331: 775-778.
297. Peters NC, Egen JG, Secundino N, Debrabant A, Kimblin N, Kamhawi S, Lawyer P, Fay MP, Germain RN, Sacks D. 2008. In vivo imaging reveals an essential role for neutrophils in leishmaniasis transmitted by sand flies. Science 321:970-974.
298. Laufs H, Muller K, Fleischer J, Reiling N, Jahnke N, Jensenius JC, Solbach W, Laskay T. 2002. Intracellular survival of Leishmania major in neutrophil granulocytes after uptake in the absence of heat-labile serum factors. Infect. Immun. 70:826-835.
299. Boggiatto PM, Jie F, Ghosh M, Gibson-Corley KN, Ramer-Tait AE, Jones DE, Petersen CA. 2009. Altered dendritic cell phenotype in response to Leishmania amazonensis amastigote infection is mediated by MAP kinase, ERK. Am. J. Pathol. 174:1818-1826.
300. Sibley LD. 2011. Invasion and intracellular survival by protozoan parasites. Immunol. Rev. 240:72-91.
301. Ueno N, Bratt CL, Rodriguez NE, Wilson ME. 2009. Differences in human macrophage receptor usage, lysosomal fusion kinetics and survival between logarithmic and metacyclic Leishmania infantum chagasi promastigotes. Cell. Microbiol. 11:1827-1841.
302. Lodge R, Descoteaux A. 2008. Leishmania invasion and phagosome biogenesis. Subcell. Biochem. 47:174-181.
303. Sacks DL. 2001. Leishmania-sand fly interactions controlling speciesspecific vector competence. Cell. Microbiol. 3:189-196.
304. Desjardins M, Descoteaux A. 1997. Inhibition of phagolysosomal biogenesis by the Leishmania lipophosphoglycan. J. Exp. Med. 185:2061-2068.
305. Huynh C, Sacks DL, Andrews NW. 2006. A Leishmania amazonensis ZIP family iron transporter is essential for parasite replication within macrophage phagolysosomes. J. Exp. Med. 203:2363-2375.
306. Lambertz U, Silverman JM, Nandan D, McMaster WR, Clos J, Foster LJ, Reiner NE. 2012. Secreted virulence factors and immune evasion in visceral leishmaniasis. J. Leukoc. Biol. 91:887-899.
307. Olivier M, Gregory DJ, Forget G. 2005. Subversion mechanisms by which Leishmania parasites can escape the host immune response: a signaling point of view. Clin. Microbiol. Rev. 18:293-305.
308. WHO. 2012. Leishmaniasis: epidemiology and access to medicines. WHO, Geneva, Switzerland.
309. Gonzalez C, Wang O, Strutz SE, Gonzalez-Salazar C, Sanchez-Cordero V, Sarkar S. 2010. Climate change and risk of leishmaniasis in North America: predictions from ecological niche models of vector and reservoir species. PLoS Negl. Trop. Dis. 4:e585. doi:10.1371/journal.pntd .0000585.
310. Faulde M, Schrader J, Heyl G, Amirih M, Hoerauf A. 2008. Zoonotic cutaneous leishmaniasis outbreak in Mazar-e Sharif, northern Afghanistan: an epidemiological evaluation. Int. J. Med. Microbiol. 298:543-550.
311. Barnes JC, Stanley O, Craig TM. 1993. Diffuse cutaneous leishmaniasis in a cat. J. Am. Vet. Med. Assoc. 202:416-418.
312. Sellon RK, Menard MM, Meuten DJ, Lengerich EJ, Steurer FJ, Breitschwerdt EB. 1993. Endemic visceral leishmaniasis in a dog from Texas. J. Vet. Intern. Med. 7:16-19.
313. Craig TM, Barton CL, Mercer SH, Droleskey BE, Jones LP. 1986. Dermal leishmaniasis in a Texas cat. Am. J. Trop. Med. Hyg. 35:1100-1102.
314. Barrett TV, Senra MS. 1989. Leishmaniasis in Manaus, Brazil. Parasitol. Today 5:255-257.
315. Desjeux P. 2001. Worldwide increasing risk factors for leishmaniasis. Med. Microbiol. Immunol. 190:77-79.
316. Jirmanus L, Glesby MJ, Guimaraes LH, Lago E, Rosa ME, Machado PR, Carvalho EM. 2012. Epidemiological and clinical changes in American tegumentary leishmaniasis in an area of Leishmania (Viannia) braziliensis transmission over a 20-year period. Am. J. Trop. Med. Hyg. 86:426-433.
317. Votypka J, Kasap OE, Volf P, Kodym P, Alten B. 2012. Risk factors for cutaneous leishmaniasis in Cukurova region, Turkey. Trans. R. Soc. Trop. Med. Hyg. 106:186-190.
318. Morrone A, Pitidis A, Pajno MC, Dassoni F, Latini O, Barnabas GA, Padovese V. 2011. Epidemiological and geographical aspects of leishmaniasis in Tigray, northern Ethiopia: a retrospective analysis of medical records, 2005-2008. Trans. R. Soc. Trop. Med. Hyg. 105:273-280.
319. Reithinger R, Mohsen M, Leslie T. 2010. Risk factors for anthroponotic cutaneous leishmaniasis at the household level in Kabul, Afghanistan. PLoS Negl. Trop. Dis. 4:e639. doi:10.1371/journal.pntd.0000639.
320. Pedrosa FA, Ximenes RA. 2009. Sociodemographic and environmental risk factors for American cutaneous leishmaniasis (ACL) in the State of Alagoas, Brazil. Am. J. Trop. Med. Hyg. 81:195-201.
321. Dahroug MA, Almeida AB, Sousa VR, Dutra V, Turbino NC, Nakazato L, de Souza RL. 2010. Leishmania (Leishmania) chagasi in captive wild felids in Brazil. Trans. R. Soc. Trop. Med. Hyg. 104:73-74.
322. Michel G, Pomares C, Ferrua B, Marty P. 2011. Importance of worldwide asymptomatic carriers of Leishmania infantum (L. chagasi) in human. Acta Trop. 119:69-75.
323. Boggiatto PM, Gibson-Corley KN, Metz K, Gallup JM, Hostetter JM, Mullin K, Petersen CA. 2011. Transplacental transmission of Leishmania infantum as a means for continued disease incidence in North America. PLoS Negl. Trop. Dis. 5:e1019. doi:10.1371/journal.pntd.0001019.
324. Dujardin JC, Campino L, Canavate C, Dedet JP, Gradoni L, Soteriadou K, Mazeris A, Ozbel Y, Boelaert M. 2008. Spread of vector-borne diseases and neglect of leishmaniasis, Europe. Emerg. Infect. Dis. 14: 1013-1018.
325. Galvez R, Miro G, Descalzo MA, Nieto J, Dado D, Martin O, Cubero E, Molina R. 2010. Emerging trends in the seroprevalence of canine leishmaniasis in the Madrid region (central Spain). Vet. Parasitol. 169: 327-334.
326. Alvar J, Velez ID, Bern C, Herrero M, Desjeux P, Cano J, Jannin J, den Boer M. 2012. Leishmaniasis worldwide and global estimates of its incidence. PLoS One 7:e35671. doi:10.1371/journal.pone.0035671.
327. de Almeida AS, Medronho RA, Werneck GL. 2011. Identification of risk areas for visceral leishmaniasis in Teresina, Piaui State, Brazil. Am. J. Trop. Med. Hyg. 84:681-687.
328. Harhay MO, Olliaro PL, Vaillant M, Chappuis F, Lima MA, Ritmeijer K, Costa CH, Costa DL, Rijal S, Sundar S, Balasegaram M. 2011. Who is a typical patient with visceral leishmaniasis? Characterizing the demographic and nutritional profile of patients in Brazil, East Africa, and South Asia. Am. J. Trop. Med. Hyg. 84:543-550.
329. Esch KJ, Pontes NN, Arruda P, O'Connor A, Morais L, Jeronimo SM, Petersen CA. 2012. Preventing zoonotic canine leishmaniasis in northeastern Brazil: pet attachment and adoption of community leishmania prevention. Am. J. Trop. Med. Hyg. 87:822-831.
330. Pagliano P, Carannante N, Rossi M, Gramiccia M, Gradoni L, Faella FS, Gaeta GB. 2005. Visceral leishmaniasis in pregnancy: a case series and a systematic review of the literature. J. Antimicrob. Chemother. 55: 229-233.
331. Nascimento ET, Moura ML, Queiroz JW, Barroso AW, Araujo AF, Rego EF, Wilson ME, Pearson RD, Jeronimo SM. 2011. The emergence of concurrent HIV-1/AIDS and visceral leishmaniasis in Northeast Brazil. Trans. R. Soc. Trop. Med. Hyg. 105:298-300.
332. Cortese L, Terrazzano G, Piantedosi D, Sica M, Prisco M, Ruggiero G, Ciaramella P. 2011. Prevalence of anti-platelet antibodies in dogs naturally co-infected by Leishmania infantum and Ehrlichia canis. Vet. J. 188:118-121.
333. Aresu L, Valenza F, Ferroglio E, Pregel P, Uslenghi F, Tarducci A, Zanatta R. 2007. Membranoproliferative glomerulonephritis type III in a simultaneous infection of Leishmania infantum and Dirofilaria immitis in a dog. J. Vet. Diagn. Invest. 19:569-572.
334. Blackwell JM, Fakiola M, Ibrahim ME, Jamieson SE, Jeronimo SB, Miller EN, Mishra A, Mohamed HS, Peacock CS, Raju M, Sundar S, Wilson ME. 2009. Genetics and visceral leishmaniasis: of mice and man. Parasite Immunol. 31:254-266.
335. Soto J, Medina F, Dember N, Berman J. 1995. Efficacy of permethrinimpregnated uniforms in the prevention of malaria and leishmaniasis in Colombian soldiers. Clin. Infect. Dis. 21:599-602.
336. Rojas CA, Weigle KA, Tovar R, Morales AL, Alexander B. 2006. A multifaceted intervention to prevent American cutaneous leishmaniasis in Colombia: results of a group-randomized trial. Biomedica 26(Suppl 1):152-166.
337. Mutinga MJ, Renapurkar DM, Wachira DW, Basimike M, Mutero CM. 1993. A bioassay to evaluate the efficacy of permethrin-impregnated screens used against phlebotomine sandflies (Diptera: Psychodidae) in Baringo District of Kenya. East Afr. Med. J. 70:168-170.
338. Tesh RB. 1995. Control of zoonotic visceral leishmaniasis: is it time to change strategies? Am. J. Trop. Med. Hyg. 52:287-292.
339. Costa CH. 2011.Howeffective is dog culling in controlling zoonotic visceral leishmaniasis? A critical evaluation of the science, politics and ethics behind this public health policy. Rev. Soc. Bras. Med. Trop. 44:232-242.
340. Harhay MO, Olliaro PL, Costa DL, Costa CH. 2011. Urban parasitology: visceral leishmaniasis in Brazil. Trends Parasitol. 27:403-409.
341. Courtenay O, Kovacic V, Gomes PA, Garcez LM, Quinnell RJ. 2009. A long-lasting topical deltamethrin treatment to protect dogs against visceral leishmaniasis. Med. Vet. Entomol. 23:245-256.
342. Quinnell RJ, Courtenay O. 2009. Transmission, reservoir hosts and control of zoonotic visceral leishmaniasis. Parasitology 136:1915-1934.
343. Saunders LZ. 2000. Virchow's contributions to veterinary medicine: celebrated then, forgotten now. Vet. Pathol. 37:199-207.
344. WHO. 2011. Managing zoonotic public health risks at the humananimal- ecosystem interface. World Health Organization, Geneva, Switzerland.
345. Allen K, Blascovich J, Mendes WB. 2002. Cardiovascular reactivity and the presence of pets, friends, and spouses: the truth about cats and dogs. Psychosom. Med. 64:727-739.
346. Arhant-Sudhir K, Arhant-Sudhir R, Sudhir K. 2011. Pet ownership and cardiovascular risk reduction: supporting evidence, conflicting data and underlying mechanisms. Clin. Exp. Pharmacol. Physiol. 38: 734-738.
347. Bergroth E, Remes S, Pekkanen J, Kauppila T, Buchele G, Keski-Nisula L. 2012. Respiratory tract illnesses during the first year of life: effect of dog and cat contacts. Pediatrics 130:211-220.
348. Gerseler PJ, Ito JI, Tegtmeier BR, Kerndt PR, Krance R. 1988. Fulminant Chagas disease in bone marrow transplantation, abstr 418. Abstr. 27th Intersci. Conf. Antimicrob. Agents Chemother., Washington, DC.
349. Kirchoff LV. 2011. American trypanosomiasis (Chagas disease), chapter 99. In Guerrant RL, Walker DH, Weller PF (ed), Tropical infectious diseases: principles, pathogens, and practice. Elsevier, Amsterdam, Netherlands.
350. Jeronimo SMB, Sousa AQ, Pearson RD. 2011. Leishmaniasis, chapter 100. In Guerrant RL, Walker DH, Weller PF (ed), Tropical infectious diseases: principles, pathogens, and practice. Elsevier, Amsterdam, Netherlands.